(Q72880757)
Statements
Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies (English)
B Vialettes
M A Guillerand
P Viens
A M Stoppa
D Baume
R Sauvan
J Pasquier
M San Marco
D Olive
D Maraninchi